This gazette notification lists drugs, medical devices, and cosmetics declared as Not of Standard Quality (NSQ), Spurious, Adulterated, or Misbranded for the month of June 2023.
Out of 1273 samples tested, 1225 were declared as of Standard Quality, 48 as Not of Standard Quality, 1 as Spurious, and none as Misbranded.
Key Changes
48 samples were declared as Not of Standard Quality due to reasons such as failure in assay, dissolution, related substances, description, identification and disintegration tests.
1 sample of Heparin Inj. I.P. 1000 IU/ml (Batch No. DP2127) manufactured by Divine Laboratories Pvt. Ltd. was declared as Spurious due to failure in Identification and Potency of Heparin.
The listed products failed to meet quality standards based on tests conducted by CDSCO (Central Drugs Standard Control Organization) and State Drug Control Departments.
The products listed are manufactured by various companies located across India, including Himachal Pradesh, Punjab, Uttarakhand, Maharashtra, Gujarat, Karnataka, Tamil Nadu, West Bengal, Sikkim and others.
The reasons for declaring products as NSQ include issues with assay of active ingredients (e.g., Aspirin, Clopidogrel, Ifosfamide, Rosuvastatin, Salmeterol, Fluticasone Propionate, Methylcobalamin), dissolution issues, presence of related substances, incorrect description, disintegration and uniformity of weight.
Impact Analysis
Manufacturers
Manufacturers should review their quality control processes, raw material sourcing, and manufacturing practices to ensure compliance with standards.
Distributors/Retailers
Implement robust tracking and tracing systems to quickly identify and remove substandard products from the supply chain.
Consumers/Patients
Healthcare professionals should be informed about the list of NSQ/Spurious drugs to avoid prescribing them to patients.
Regulatory Authorities (CDSCO/State Drug Control)
Enhance collaboration between central and state drug regulatory authorities to improve coordination and information sharing.
Key Entities Referenced
CDSCO: Central Drugs Standard Control Organization, the national regulatory body for pharmaceuticals and medical devices in India.
State Drug Control Departments: State-level regulatory bodies responsible for enforcing drug regulations within their respective states.
Salus Pharmaceuticals: Manufacturer of Clorin Capsules (Aspirin & Clopidogrel Capsules), batch SPC221847, which failed assay and dissolution tests.
Astrica Healthcare Pvt. Ltd.: Manufacturer of Astrifos 2 gm (Ifosfamide Injection IP with Mesna Injection), batch OL220037A, which failed assay test.
Synokem Phramaceuticals Ltd.: Manufacturer of Rosuvastatin & Vitamin D3 Tablets, batch 22S1GTA576, which failed assay test.
CMG Biotech Pvt. Ltd.: Manufacturer of CGTROM-1 (Nicoumalone Tablets IP), batch CT22231818 and Manokast 5 (Montelukast Tablets IP), batch CT22230271A, which failed related substances and assay tests respectively.
Alves Healthcare Private Limited: Manufacturer of Erythromycin Stearate Tablets IP 250 mg, batch AT22356, which failed dissolution test.
Gnosis Pharmaceuticals Pvt. Ltd.: Manufacturer of Keraboost (Tablets of D-Biotin, N-Acetyl L-Cysteine, Vitamins & Minerals), batch GT200998, which failed description and assay of Calcium Pantothenate tests.
Stanford Laboratories Private Limited: Manufacturer of NUHENZ (Methylcobalamin, Alpha Lipoic acid, Myo-Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide Monohydrate & Benfotaimine Capsules), batches D222427 and D222376, which failed assay of Alpha Lipoic acid test.
Maxheal Pharmaceuticals (India) Ltd.: Manufacturer of Maxflux 100 ml (Flucloxacillin Oral solution BP 125mg/5ml), batches M481001, M481002, M481003 and M481004, which failed assay of Flucloxacillin test.
Aan Pharma Private Limited: Manufacturer of Anabol Syrup (Cyproheptadine Hydrochloride Syrup IP), batch L22556, which failed assay of Cyproheptadine Hydrochloride test.
Stallion Laboratories Pvt. Ltd.: Manufacturer of Glipizide Tablets I.P. 5 mg, batch T3180, which failed dissolution test.
Indiana Ophthalmics LLP: Manufacturer of IO-Pred-S Eye Drops (Prednisolone Acetate Ophthalmic Suspension USP), batches N22L17 and N22L18, which failed assay of Prednisolone Acetate test.
Karnataka Antibiotics & Pharmaceuticals Limited: Manufacturer of Ofloxacin and Ornidazole Tablets IP, batch 6001022, which failed description test.
Unicure India Ltd.: Manufacturer of Prednisolone Tablets I.P. 5 mg, batch PDT1009 and CLOZAPINE TABLETS I.P. 100 MG, batch CZPT1006, which failed related substances and assay tests respectively.
Oxalis Labs: Manufacturer of Flutrol 250 (Salmeterol and Fluticasone Propionate Inhalation I.P.), batch NSB2206A, which failed assay of Salmeterol Xinafoate and Fluticasone Propionate test.
Mascot Health Series Pvt. Ltd.: Manufacturer of Aceclofenac Tablets I.P. (100 mg), batch MT224501 and Aluminium Hydroxide (0.291 gm), Magnesium Hydroxide (98 mg) and Oxetacaine (10 mg ) Gel, batch ML220582, which failed dissolution and assay of Oxetacaine tests respectively.
Hindustan Antibiotics Ltd.: Manufacturer of Paracetamol Tablets I.P. 650 mg, batch 0019 and CETIRIZINE TABLETS IP 10 mg, batch 0051, which failed dissolution and related substances tests respectively.
Apple Formulations Pvt. Ltd.: Manufacturer of Glimkar-4 (Glimepiride Tablets 4 mg), batch GKR-2210, which failed dissolution test.
Macleods Pharmaceuticals Ltd.: Manufacturer of Acenomac 1 (Nicoumalone Tablets IP), batch FNU02202A, which failed related substances test.
Saar Biotech: Manufacturer of Mupirocin Ointment IP 2% w/w, batch 002, which failed assay test.
Divine Laboratories Pvt. Ltd.: Manufacturer of FLAGORIN (Heparin Inj. I.P. 1000 IU/ml), batch DP2127, which failed Identification and Potency of Heparin test and deemed to be Spurious.
DM PHARMA PRIVATE LIMITED: Manufacturer of Telmisartan Tablets IP 40 mg (TLS-40 TABLETS), batch DT0862B, which failed dissolution test.
NESTOR PHARMACEUTICALS LIMITED: Manufacturer of Aciclovir Tablets IP 400 mg, batch YCTZ-01, which failed assay of Aciclovir test.
Trugen Pharmaceuticals Pvt. Ltd.: Manufacturer of Telmisartan Tablets IP 40 mg (Telwin-40 Tablets), batch TT230416, which failed dissolution test.
LA-CHEMICO PRIVATE LIMITED: Manufacturer of Zinc Sulphate Dispersible Tablets IP, batch ZST22015, which failed disintegration test.
ZEE LABORATORIES LTD.: Manufacturer of Acetazolamide Tablets IP 250 mg, batch 423-27, which failed uniformity of weight test.
Cooper Pharma Ltd.: Manufacturer of NOOPHIN (BUPRENORPHIN E INJECTION I.P. 2ml), batch LM18920, which failed Related substances test.
BITECH LABORATORY: Manufacturer of Diclofenac Sodium Injection IP INDORE-452015 (M.P.) DOLOMAX 25mg/ml, batch FDF1-098, which failed Assay test.
CADILA PHARMACEUTICALS LIMITED: Manufacturer of RANITIDINE TABLETS IP 150mg (ACILOC 150), batch LD21512, which failed Description test.
Wings biotech LLP: Manufacturer of Chlorpheniramine Maleate & Codeine Phosphate Syrup ONEREX™ COUGH SYRUP, batch ONCS 1713, which failed Identification and Assay of Codeine phosphate test.
ALKEM HEALTH SCIENCE: Manufacturer of Pantoprazole Gastro- Resistant Tablets IP (PAN*40), batches 22440483 and 22441073, which failed Assay of Pantoprazole test.
Phytochem Healthcare: Manufacturer of Panqub™ DSR Capsules (Pantoprazole Sodium (GR) & Domperidone (PR) Capsules I.P.), batch PHC-21252, which failed Dissolution of Domperidone test.
Anant Pharmaceuticals: Manufacturer of Ceeti-LM (Levocetirizine & Montelukast Sodium Tablets I.P.), batch ALT-0432, which failed Dissolution of Montelukast and Levocetirizine Hydrochloride test.
ADROIT PHARMACEUTICALS Pvt. Ltd: Manufacturer of DICLOFENAC SODIUM TABLETS I.P.50 mg, batch TS7464, which failed Test for Disintegration (Acid Stage) test.
HIPPO LABS PVT. LTD: Manufacturer of ALUMINIUM HYDROXIDE ,MAGNESIUM HYDROXIDE & ACTIVATED DIMETHICONE SUSPENSION (HICID-MPS SUSPENSION), batch HCD 2201, which failed Weight per ml test.
VANCE & HEALTH PHARMACEUTICALS PVT. LTD: Manufacturer of ALBENDAZOLE TABLETS I.P. 400 MG (FOZY), batch RD09-2202, which failed Test for Dissolution test.
JPEE DRUGS: Manufacturer of PANTOPRAZOLE GASTRO RESISTANT TABLETS IP 40 MG, batches JDT-7092 and JDT-7132, which failed Test for Dissolution (Buffer Stage) test.
HANUCHEM LABORATORIES: Manufacturer of TELMISARTAN TABLETS IP 20 MG (TELTAN 20), batch HCL2317, which failed Test for Dissolution test.